Impact of mass screening for gluten-sensitive enteropathy in working population

Table 5 Patients who accepted follow-up but did not adhere to GFD

	At basal evaluation					Follow-up
	Clinical features	EmA	tTGA (U/mL)	Biopsy	IELs	Clinical features	EmA	tTGA (U/mL)	Biopsy	IELs
Case 1 male 23 years	Flatulence, distension, abdominal pain, diarrhea, asthenia	1/40	6.76	Marsh IIIb	----	Flatulence, distension, abdominal pain, diarrhea, asthenia	Neg.	1.70	Not accepted	---
Case 2 male 63 years	Osteopenia	Neg.	4.07	Marsh I	29%	Osteopenia	Neg.	2.2	Marsh I	25%
Case 3 male 24 years	Flatulence, distension, abdominal pain, diarrhea, asthenia	Neg.	3.47	Marsh I	25%	Flatulence, distension, diarrhea, asthenia	Neg.	1.0	Not accepted	---
Case 4 female 66 years	Flatulence, distension, abdominal pain	Neg.	5.60	Marsh I	35%	Diarrhea, abdominal pain, distension, flatulence	Neg.	15	Marsh IIIa	---
Case 5 male 45 years	Asthenia	Neg.	2.68	Marsh 0	5%	Asthenia	Neg.	2.0	Marsh I	28%
Case 6 male 47 years	Flatulence	Neg.	3.95	Marsh 0	22%	Flatulence	Neg.	1.0	Marsh 0	5%
Case 7 male 36 years	Distension	Neg.	2.78	Marsh 0	20%	Distension, hypertransaminasemia	Neg.	1.2	Not accepted	---
Case 8 male 36 years	Flatulence	Neg.	2.80	Marsh 0	18%	Flatulence	Neg.	1.0	Not accepted	---